Approval · Notice of Compliance 10765 · 2009
NU-INDAPAMIDE: Notice of Compliance 10765
Issued November 6, 2009
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 10765
- Date
- November 6, 2009
- Company
- Nu-Pharm IncVaughan, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Admin
- Reason
- New strength
- Therapeutic class
- Diuretic / Antihypertensive agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NU-INDAPAMIDE | 02337118 | Cancelled (Unreturned Annual) |
Medicinal ingredients
- INDAPAMIDE 1.25 MG per TAB